RCP DIAGNOSTICS LICENSES ITS PROTEIN MARKER TO BIOMARKER TECHNOLOGIES

RCP Diagnostics announced today that they have entered into a licensing agreement with Biomarker Technologies to allow Biomarker to use RCP's protein marker, riboflavin carrier protein, in conjunction with Biomarker's blood diagnostic for breast cancer, called the BT Test.
PR Newswire